Literature DB >> 20628747

Gil-Vernet antireflux surgery in children's primary vesicoureteral reflux.

Alireza Mirshemirani1, Ahmad Khaleghnejad Tabari, Fatollah Roshanzamir, Shahnaz Shayeghi.   

Abstract

PURPOSE: The assessment of the results of Gil-Vernet antireflux surgery in children with primary vesicoureteral reflux.
MATERIALS AND METHODS: In a descriptive retrospective study, 72 patients with vesicoureteral reflux (VUR) and 104 refluxing units underwent Gil-Vernet antireflux surgery in Mofid children's hospital from Dec 2000 to Nov 2005. The study group was selected from among the patients with VUR who had been operated in our center. Data were collected from the medical records of the patients in the archive of the hospital and analyzed for gender, age, method of diagnosis, side of involvement, grading types, usage of catheter and stent, operating time, hospital stay, reflux down grading, operative success rate, recurrence and operative complication.
RESULTS: Among 72 patients, 47 (65%) were females and 25 (35%) were males with a mean age of 4.35 ± 2.96 years (range 1-13 years). 32 patients had bilateral and 40 had unilateral reflux, and 76% were in grades III and IV. Mean operative time was 55 ± 13 min, median hospital stay was 2 ± 0.9 days and mean follow-up period was 48 ± 9 months. Reflux was improved completely in 100 (96.15%) refluxing units, and down-graded in 4 (3.84%) units. Treatment was performed medically in 2 and surgically in 2 refluxing units, and all were improved successfully. There were no complications post-operatively.
CONCLUSION: Gil-Vernet antireflux technique is a useful method, and it has many advantages such as simplicity, shorter operative time, lower complication rate and high success rate.

Entities:  

Mesh:

Year:  2010        PMID: 20628747     DOI: 10.1007/s00383-010-2651-0

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  11 in total

1.  URINARY TRACT INFECTION IN SCHOOL CHILDREN: AN EPIDEMIOLOGIC, CLINICAL AND LABORATORY STUDY.

Authors:  C M KUNIN; R DEUTSCHER; A PAQUIN
Journal:  Medicine (Baltimore)       Date:  1964-03       Impact factor: 1.889

2.  Trigonoplasty to treat secondary vesicoureteral reflux in neurogenic bladders.

Authors:  Jimao Zhao; Yuhai Zhang; Wencheng Lu
Journal:  Urol Int       Date:  2005       Impact factor: 2.089

Review 3.  Vesicoureteral reflux.

Authors:  Larry A Greenbaum; Hrair-George O Mesrobian
Journal:  Pediatr Clin North Am       Date:  2006-06       Impact factor: 3.278

Review 4.  Vesicoureteral reflux.

Authors:  David G Bundy
Journal:  Pediatr Rev       Date:  2007-02

5.  Results of modified Gil-Vernet antireflux surgery in the treatment of vesicoureteral reflux.

Authors:  D Irani; M Heidari
Journal:  Urol J       Date:  2004       Impact factor: 1.510

Review 6.  Vesico-ureteric reflux: occurrence and long-term risks.

Authors:  S H Jacobson; S Hansson; B Jakobsson
Journal:  Acta Paediatr Suppl       Date:  1999-11

7.  Extraperitoneal laparoscopic trigonoplasty for treatment of vesicoureteral reflux: novel technique duplicating its open counterpart.

Authors:  Nasser Simforoosh; Mohammad Nadjafi-Semnani; Saeed Shahrokhi
Journal:  J Urol       Date:  2007-01       Impact factor: 7.450

8.  Management of vesicoureteral reflux without indwelling catheter and drain, using trigonoplasty technique.

Authors:  Nasser Simforoosh; Homa Hariri
Journal:  J Pediatr Urol       Date:  2008-08-03       Impact factor: 1.830

9.  A new technique for surgical correction of vesicoureteral reflux.

Authors:  J M Gil-Vernet
Journal:  J Urol       Date:  1984-03       Impact factor: 7.450

10.  Gil-Vernet antireflux surgery in treatment of lower pole reflux.

Authors:  Fahimeh Kazemi-Rashed; Nasser Simforoosh
Journal:  Urol J       Date:  2005       Impact factor: 1.510

View more
  1 in total

1.  The Modified Gil-Vernet Antireflux Surgery: A Successful Technique for High-Grade Vesicoureteral Reflux Correction in Children-Long-Term Follow-Up.

Authors:  Mahmoudreza Moradi; Abolhassan Seyedzadeh; Saeed Gharakhloo; Aref Teymourinezhad; Kaveh Kaseb; Haress Rezaee
Journal:  Adv Urol       Date:  2018-10-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.